Transporters associated with antigen processing (TAP)-independent presentation of soluble insulin to α/β T cells by the class Ib gene product, Qa-1(b)

Journal of Experimental Medicine

Volumn 188, Issue 5, 1998, Pages 961-971

  Tompkins, S Mark ^a   Kraft, Jennifer R ^a   Dao, Chinh T ^a   Soloski, Mark J ^b   Jensen, Peter E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antigen processing; Class Ib molecules; Insulin; Major histocompatibility proteins; T cells

Indexed keywords

GENE PRODUCT; INSULIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; FEMALE; HYBRIDOMA; INSULIN BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; CATTLE; COS CELLS; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HYBRIDOMAS; INSULIN; MICE; MICE, INBRED A; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SOLUBILITY; SPLEEN; SWINE; T-LYMPHOCYTE SUBSETS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032494096     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.5.961     Document Type: Article

References (73)

1. Shawar, S.M., J.M. Vyas, J.R. Rodgers, and R.R. Rich. 1994. Antigen presentation by major histocompatibility complex class I-B molecules. Annu. Rev. Immunol. 12:839-880.
2. Teitell, M., H. Cheroutre, C. Panwala, H. Holcombe, P. Eghtesady, and M. Kronenberg. 1994. Structure and function of H-2 T (Tla) region class I MHC molecules. Crit. Rev. Immunol. 14:1-27.
3. Flaherty, L., E. Elliott, J.A. Tine, A.C. Walsh, and J.B. Waters. 1990. Immunogenetics of the Q and TL regions of the mouse. Crit. Rev. Immunol. 10:131-175.
4. Lindahl, K.F., D.E. Byers, V.M. Dabhi, R. Hovik, E.P. Jones, G.P. Smith, C.R. Wang, H. Xiao, and M. Yoshino. 1997. H2-M3, a full-service class Ib histocompatibility antigen. Annu. Rev. Immunol. 15:851-879.
5. Harty, J.T., and M.J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity. 3: 109-117.
6. Sugita, M., R.M. Jackman, E. van Donselaar, S.M. Behar, R.A. Rogers, P.J. Peters, M.B. Brenner, and S.A. Porcelli. 1996. Cytoplasmic tail-dependent localization of CD1b antigen-presenting molecules to MIICs. Science. 273:349-352.
7. Beckman, E.M., S.A. Porcelli, C.T. Morita, S.M. Behar, S.T. Furlong, and M.B. Brenner. 1994. Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature. 372: 691-694.
8. Sieling, P.A., D. Chatterjee, S.A. Porcelli, T.I. Prigozy, R.J. Mazzaccaro, T. Soriano, B.R. Bloom, M.B. Brenner, M. Kronenberg, and P.J. Brennan. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science. 269: 227-230.
9. Stanton, T.H., and E.A. Boyse. 1976. A new serologically defined locus, Qa-1, in the Tla-region of the mouse. Immunogenetics. 3:525-531.
10. Klein, J., and C.L. Chiang. 1978. A new locus (H-2T) at the D end of the H-2 complex. Immunogenetics. 6:235-243.
11. Lindahl, K.F., and J. Langhorne. 1981. Medial histocompatibility antigens. Scand. J. Immunol. 14:643-654.
12. Jenkins, R.N., C.J. Aldrich, L.A. Lopez, and R.R. Rich. 1985. Oligosaccharide-dependent and independent Qa-1 determinants. J. Immunol. 134:3218-3225.
13. Soloski, M.J., A. DeCloux, C.J. Aldrich, and J. Forman. 1995. Structural and functional characteristics of the class IB molecule, Qa-1. Immunol. Rev. 147:67-89.
14. Lalanne, J.L., C. Transy, S. Guerin, S. Darche, P. Meulien, and P. Kourilsky. 1985. Expression of class I genes in the major histocompatibility complex: identification of eight distinct mRNAs in DBA/2 mouse liver. Cell. 41:469-478.
15. Wolf, P.R., and R.G. Cook. 1990. The TL region gene 37 encodes a Qa-1 antigen. J. Exp. Med. 172:1795-1804.
16. Connolly, D.J., L.A. Cotterill, R.A. Hederer, C.J. Thorpe, P.J. Travers, J.H. McVey, J. Dyson, and P.J. Robinson. 1993. A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J. Immunol. 151:6089-6098.
17. Aldrich, C.J., J.R. Rodgers, and R.R. Rich. 1988. Regulation of Qa-1 expression and determinant modification by an H-2D-linked gene, Qdm. Immunogenetics. 28:334-344.
18. Aldrich, C.J., A. DeCloux, A.S. Woods, R.J. Cotter, M.J. Soloski, and J. Forman. 1994. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for 3 class Ib antigen. Cell. 79:649-658.
19. DeCloux, A., A.S. Woods, R.J. Cotter, M.J. Soloski, and J. Forman. 1997. Dominance of a single peptide bound to the class Ib molecule, Qa-1b. J. Immunol. 158:2183-2191.
20. Cotterill, L.A., H.J. Stauss, M.M. Millram, D.J. Pappin, D. Rahman, B. Canas, P. Chandler, A. Stackpoole, E. Simpson, P.J. Robinson, and P.J. Dyson. 1997. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur. J. Immunol. 27:2123-2132.
21. Vidovic, D., M. Roglic, K. McKune, S. Guerder, C. MacKay, and Z. Dembic. 1989. Qa-1 restricted recognition of foreign antigen by a gamma delta T-cell hybridoma. Nature. 340:646-650.
22. Imani, F., and M.J. Soloski. 1991. Heat shock proteins can regulate expression of the Tla region-encoded class Ib molecule Qa-1. Proc. Natl. Acad. Sci. USA. 88:10475-10479.
23. Jiang, H., R. Ware, A. Stall, L. Flaherty, L. Chess, and B. Pernis. 1995. Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity. 2:185-194.
24. Bouwer, H.G., M.S. Seaman, J. Forman, and D.J. Hinrichs. 1997. MHC class Ib-restricted cells contribute to antilisterial immunity: evidence for Qa-1b as a key restricting element for Listeria-specific CTLs. J. Immunol. 159:2795-2801.
25. Jensen, P.E., and A.O. Kraft. 1990. T cells from nonresponder mice. MHC restricted and unrestricted recognition of insulin. J. Immunol. 145:3985-3991.
26. Martin, W.D., G.G. Hicks, S.K. Mendiratta, H.I. Leva, H.E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 84:543-550.
27. Van Kaer, L., P.G. Ashton-Rickardt, H.L. Ploegh, and S. Tonegawa. 1992. Tap1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-CD8+ T cells. Cell. 71:1205-1214.
28. Elliott, E.A., J.R. Drake, S. Amigorena, J. Elsemore, P. Webster, I. Mellman, and R.A. Flavell. 1994. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179:681-694.
29. Hamano, T., K.J. Kim, W.M. Leiserson, and R. Asofsky. 1982. Establishment of B cell hybridomas with B cell surface antigen. J. Immunol. 129:1403-1406.
30. Kappler, J., J. White, D. Wegmann, E. Mustain, and P. Marrack. 1982. Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas. Proc. Natl. Acad. Sci. USA. 79:3604-3607.
31. Kim, K.J., C. Kanellopoulos-Langevin, R.M. Merwin, D.H. Sachs, and R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:549-554.
32. Herberman, R.B. 1972. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus. J. Natl. Cancer Inst. 48:265-271.
33. White, J., M. Blackman, J. Bill, J. Kappler, P. Marrack, D.P. Gold, and W. Born. 1989. Two better cell lines for making hybridomas expressing specific T cell receptors. J. Immunol. 143:1822-1825.
34. Estin, C.D., U. Stevenson, M. Kahn, I. Hellstrom, and K.E. Hellstrom. 1989. Transfected mouse melanoma lines that express various levels of human melanoma-associated antigen p97. J. Natl. Cancer Inst. 81:445-448.
35. Accili, D., J. Drago, E.J. Lee, M.D. Johnson, M.H. Cool, P. Salvatore, L.D. Asico, P.A. Jose, S.I. Taylor, and H. Westphal. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12:106-109.
36. Gu, J.J., and P.D. Gottlieb. 1992. Inducible functions in hybrids of a Lyt-2+ BW5147 transfectant and the 2C CTL line. Immunogenetics. 36:283-293.
37. Gluzman, Y. 1981. SV40-transformed simian cells support the replication of early SV40 mutants. Cell. 23:175-182.
38. Reis e Sousa, C., and R.N. Germain. 1995. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182:841-851.
39. Tompkins, S.M., J.C. Moore, and P.E. Jensen. 1996. An insulin peptide that binds an alternative site in class II major histocompatibility complex. J. Exp. Med. 183:857-866.
40. Ito, K., L. Van Kaer, M. Bonneville, S. Hsu, D.B. Murphy, and S. Tonegawa. 1990. Recognition of the product of a novel MHC TL region gene (27b) by a mouse gamma delta T cell receptor. Cell. 62:549-561.
41. Weintraub, B.C., M.R. Jackson, and S.M. Hedrick. 1994. Gamma delta T cells can recognize nonclassical MHC in the absence of conventional antigenic peptides. J. Immunol. 153: 3051-3058.
42. Morita, A., T. Takahashi, E. Stockert, E. Nakayama, T. Tsuji, Y. Matsudaira, L.J. Old, and Y. Obata. 1994. TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells. J. Exp. Med. 179:777-784.
43. Sharma, P., S. Joyce, K.A. Chorney, J.W. Griffith, R.H. Bonneau, F.D. Wilson, C.A. Johnson, R.A. Flavell, and M.J. Chorney. 1996. Thymus-leukemia antigen interacts with T cells and self-peptides. J. Immunol. 156:987-996.
44. Kurepa, Z., and J. Forman. 1997. Peptide binding to the class Ib molecule, Qa-1b. J. Immunol. 158:3244-3251.
45. 125I]insulin to the plasma membrane and its relation to insulin bioactivity. Proc. Natl. Acad. Sci. USA. 68:1833-1837.
46. Rock, K.L., S. Gamble, and L. Rothstein. 1990. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science. 249:918-921.
47. Rock, K.L., L. Rothstein, S. Gamble, and C. Fleischacker. 1993. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules. J. Immunol. 150:438-446.
48. Norbury, C.C., L.J. Hewlett, A.R. Prescott, N. Shastri, and C. Watts. 1995. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity. 3:783-791.
49. Bachmann, M.F., M.B. Lutz, G.T. Layton, S.J. Harris, T. Fehr, M. Rescigno, and P. Ricciardi-Castagnoli. 1996. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Eur. J. Immunol. 26:2595-2600.
50. Shen, Z., G. Reznikoff, G. Dranoff, and K.L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158: 2723-2730.
51. Norbury, C.C., B.J. Chambers, A.R. Prescott, H.G. Ljunggren, and C. Watts. 1997. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:280-288.
52. Rock, K.L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today. 17:131-137.
53. Jondal, M., R. Schirmbeck, and J. Reimann. 1996. MHC class I-restricted CTL responses to exogenous antigens. Immunity. 5:295-302.
54. Kovacsovics-Bankowski, M., and K.L. Rock. 1995. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 267:243-246.
55. Bachmann, M.F., A. Oxenius, H. Pircher, H. Hengartner, P.A. Ashton-Richardt, S. Tonegawa, and R.M. Zinkernagel. 1995. TAP 1-independent loading of class I molecules by exogenous viral proteins. Eur. J. Immunol. 25:1739-1743.
56. Pfeifer, J.D., M.J. Wick, R.L. Roberts, K. Findlay, S.J. Normark, and C.V. Harding. 1993. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 361:359-362.
57. Harding, C.V., and R. Song. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:4925-4933.
58. Sugita, M., and M.B. Brenner. 1995. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J. Biol. Chem. 270:1443-1448.
59. Sherman, M.A., D.A. Weber, and P.E. Jensen. 1995. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 3:197-205.
60. Weber, D.A., B.D. Evavold, and P.E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science. 274:618-620.
61. Suto, R., and P.K. Srivastava. 1995. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science. 269:1585-1588.
62. Ke, Y., and J.A. Kapp. 1996. Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake. J. Exp. Med. 184:1179-1184.
63. Schirmbeck, R., K. Melber, and J. Reimann. 1995. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 25: 1063-1070.
64. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K.L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA. 90:4942-4946.
65. Cochet, M., A. Casrouge, A. Dumont, C. Transy, F. Baleux, W.L. Maloy, J.E. Coligan, P. Cazenave, and P. Kourilsky. 1989. A new mouse cell surface molecule closely related to mouse class I transplantation antigens. Eur. J. Immunol. 19: 1927-1931.
66. Bouvier, M., and D.C. Wiley. 1994. Importance of peptide amino and carboxyl termini to the stability of MHC class I molecules. Science. 265:398-402.
67. Castano, A.R., S. Tangri, J.E.W. Miller, H.R. Holcombe, M.R. Jackson, W.D. Huse, M. Kronenberg, and P.A. Peterson. 1995. Peptide binding and presentation by mouse CD1. Science. 269:223-226.
68. Collins, E.J., D.N. Garboczi, and D.C. Wiley. 1994. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature. 371:626-629.
69. Aldrich, C.J., R. Waltrip, E. Hermel, M. Attaya, K.F. Lindahl, J.J. Monaco, and J. Forman. 1992. T cell recognition of Qa-1b antigens on cells lacking a functional Tap-2 transporter. J. Immunol. 149:3773-3777.
70. Balendiran, G.K., J.C. Solheim, A.C. Young, T.H. Hansen, S.G. Nathenson, and J.C. Sacchettini. 1997. The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with beta-2 microglobulin and peptide. Proc. Natl. Acad. Sci. USA. 94:6880-6885.
71. Keck, K. 1975. Ir-gene control of immunogenicity of insulin and A-chain loop as a carrier determinant. Nature. 254:78-79.
72. Carbone, A.M., P. Marrack, and J. Kappler. 1988. Remethylation at sites 5′ of the murine Lyt-2 gene in association with shutdown of Lyt-2 expression. J. Immunol. 141:1369-1375.
73. 50 (GT) in nonresponder BALB/c mice. J. Exp. Med. 142:1436-1446.